NCT04287660: Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients |
|
|
| Recruiting | 3 | 20 | RoW | clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells | The First Affiliated Hospital of Soochow University, Changshu Frist People's Hospital, Huai'an Second People's Hospital, Affiliated Hospital of Jiangnan University, Jiangsu Province Hospital of Traditional Chinese Medicine, Jiangyin People's Hospital, Jingjiang People's Hospital, The Third People's Hospital of Kunshan, Lianyungang Hospital Affiliated Bengbu Medical College, Suzhou Municipal Hospital, Zhangjiagang First People's Hospital, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, The First Affiliated Hospital with Nanjing Medical University, The first Affiliated Hospital of Nanjing University Medical School | Multiple Myeloma | 01/23 | 01/25 | | |
| Recruiting | 2 | 5 | RoW | autologous anti-BCMA chimeric antigen receptor T cells | The First Affiliated Hospital of Soochow University, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | ITP | 12/22 | 06/23 | | |
